They are using the plants as factories for an antibody chemical specific to the cells which cause follicular B-cell lymphoma, a type of non-Hodgkin’s lymphoma.

More research is needed but this could prove to be a step in the right direction,by getting the treatment from plants the cost would be cheaper and there would be less risk to the patient, reports Blogging America.

"Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants," writes Biology Biochemistry.

"Researchers examined only 16 patients suffering from follicular B-cell lymphoma. Cancer patients were injected the personalized vaccine and 70% of them did not report any adverse side effects," reports eMaxhealth on cancer vaccine and tobacco.